Citi Flags Two Biotech Stocks as 2026 Top Picks Amid Favorable Sector Outlook
Analyst Eric Joseph highlights mid-sized biotech firms for strong pipeline potential and reduced regulatory risks. Citi analyst Eric Joseph has identified two biotech stocks as top picks for 2026, citing a favorable risk-reward profile in the mid-sized segment. The sector’